Takeda Pharmaceutical Co Ltd (NYSE:TAK)
$ 13.45 -0.11 (-0.81%) Market Cap: 42.99 Bil Enterprise Value: 70.33 Bil PE Ratio: 22.63 PB Ratio: 0.94 GF Score: 79/100

Q1 2020 Takeda Pharmaceutical Co Ltd Earnings Call Transcript

Jul 31, 2019 / 09:00AM GMT
Release Date Price: $17.6 (+4.95%)
Takashi Okubo
Takeda Pharmaceutical Company Limited - Global Head of IR, Global Finance

[Interpreted] Thank you very much for participating on our earning calls for first quarter 2019, despite your busy schedule. I am the facilitator for this session. Okubo is my name, Global IR Head.

From our side, we have presenters and also respondents to the Q&A sessions, President and CEO, Christophe Weber; Chief Financial Officer, Costa Saroukos; and R&D President; Andrew Plump, joining in this call.

First, we will have a presentation for first quarter 2019 consolidated financial results from Costa, CFO, and then we will move on to the Q&A session.

Now please prepare the presentation materials at hand during the presentation.

Go ahead.

Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Director

Thank you, Takashi. Good evening, everyone. Thank you for joining Takeda's quarter 1 Conference Call. I'm delighted to say that we are off to an excellent start in the first quarter of the first full year as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot